Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $53.23 | 1 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $53.23 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $53.23 | 1 | Celgene Corporation ($53.23) |
All Payment Transactions
1 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/20/2018 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $53.23 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,344 | 4,014 | $863,817 | $154,754 |
| 2022 | 17 | 1,374 | 3,742 | $824,580 | $159,359 |
| 2021 | 15 | 1,452 | 4,058 | $860,866 | $177,917 |
| 2020 | 18 | 1,362 | 3,193 | $647,089 | $142,115 |
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 4 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88112 | Cell examination of specimen | Office | 2020 | 74 | 80 | $10,104 | $1,974 | 19.5% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Facility | 2020 | 24 | 24 | $15,600 | $1,637 | 10.5% |
| 88172 | Evaluation of fine needle aspirate | Facility | 2020 | 31 | 48 | $6,000 | $1,608 | 26.8% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Office | 2020 | 23 | 24 | $6,436 | $1,497 | 23.3% |
| 88342 | Tissue or cell analysis by immunologic technique | Facility | 2020 | 38 | 40 | $4,920 | $1,311 | 26.6% |
| 88177 | Pap test | Facility | 2020 | 27 | 41 | $3,116 | $847.72 | 27.2% |
| 88172 | Evaluation of fine needle aspirate | Office | 2020 | 16 | 16 | $2,142 | $466.55 | 21.8% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2020 | 16 | 18 | $720.00 | $193.53 | 26.9% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2020 | 26 | 27 | $432.00 | $113.32 | 26.2% |
About Qiusheng Si, M.D., PH.D
Qiusheng Si, M.D., PH.D is a Anatomic Pathology healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821213265.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Qiusheng Si, M.D., PH.D has received a total of $53.23 in payments from pharmaceutical and medical device companies, with $53.23 received in 2018. These payments were reported across 1 transactions from 1 company. The most common payment nature is "Food and Beverage" ($53.23).
As a Medicare-enrolled provider, Si has provided services to 5,532 Medicare beneficiaries, totaling 15,007 services with total Medicare billing of $634,145. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location White Plains, NY
- Active Since 04/13/2007
- Last Updated 10/20/2023
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1821213265
Products in Payments
- Abraxane (Drug) $53.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.